LU351
QUICK SCAN
For the management of benign prostatic hyperplasia where six weeks of treatment with other formulary alpha blockers (e.g.
Complete Ontario criteria
For the management of benign prostatic hyperplasia where six weeks of treatment with other formulary alpha blockers (e.g. doxazosin, terazosin, tamsulosin) have been ineffective.